BPC‐157 Research Peptide Overview
BPC‐157 (Body Protection Compound‐157) is a synthetic pentadecapeptide fragment derived from a naturally occurring gastric protein complex, investigated for its broad regenerative, angiogenic, and cytoprotective properties in preclinical models.
Molecular Composition and Mechanistic Profile
Peptide identity: BPC‐157 is a 15–amino acid peptide (pentadecapeptide)
Origin: Synthetic fragment of “body protection compound” (BPC), originally isolated from human gastric juice.
Mechanistically, BPC‐157 has been associated with:
Strong angiogenic activity: stimulation of VEGF/VEGFR2 signaling, increased endothelial cell proliferation, and enhanced “vascular running” (growth of new vessels toward injured areas).
Modulation of nitric oxide (NO) pathways via the Akt‐eNOS axis, improving blood flow, normalizing coagulation, and protecting vascular endothelium, including prevention and reversal of thrombosis in some animal models.
Direct effects on fibroblast migration and proliferation—fibroblast migration rates up to ~2.5× and outgrowth ~3× higher than control in vitro—supporting collagen synthesis and tissue remodeling.
Broad cytoprotective signaling, including ERK1/2 and FAK–paxillin activation, which enhance cell survival, adhesion, and motility at injury sites.
These overlapping pathways help explain its multi‐tissue regenerative profile in preclinical work.
Integrated Research Applications
BPC‐157 is studied across numerous tissue systems as a generalized healing and homeostasis modulator. Representative domains include:
Gastrointestinal and hepatic models: Protection against ulcers, leaky gut, IBS‐like symptoms, Crohn‐type inflammation, and toxic liver injury (e.g., CCl4, NSAID, and alcohol models), with improved mucosal healing and barrier integrity.
Muscle, tendon, and ligament repair: Accelerated healing of tendon and ligament injuries, improved muscle regeneration, and enhanced biomechanical strength, with higher local levels of growth factors such as VEGF, bFGF, and EGF in healing tissues.
Bone, joint, and neuromuscular systems: Benefits in bone repair, spinal cord and peripheral nerve injury, and neuromuscular junction stabilization, including anti‐spasticity and improved functional recovery in some animal models.
Cardiovascular and neurovascular injury: Protection in heart ischemia models, eye injuries, and various CNS insults through combined vascular, anti‐inflammatory, and antioxidative mechanisms.
Overall, BPC‐157 is used as a tool to explore coordinated healing and homeostasis restoration at the levels of blood vessels, connective tissues, and neural structures.
Analytical Validation, Formulation, and Storage
Peptide Sciences and similar vendors supply BPC‐157 primarily as a lyophilized peptide (e.g., 5 mg vials and capsule formats), labeled exclusively for research use. Typical quality and handling features include:
Purity: ≥99% verified by HPLC.
Formulation: White powder in glass vials or encapsulated; intended to be
reconstituted with appropriate solvent for experimental use, with no dosing instructions provided for humans or animals.
Storage recommendations follow standard peptide practice:
Keep lyophilized peptide in a cool, dark, dry environment; long‐term storage typically at or below −20 °C.
Store reconstituted solutions refrigerated, avoid repeated freeze–thaw cycles, and use within lab‐defined time windows.
These conditions support structural stability and reproducible activity across experiments.
NextGenPeps supplies BPC-157 as a high-purity research peptide intended strictly for controlled laboratory use in vitro or in established animal models, such as murine and canine systems. This compound is not approved as a drug, diagnostic, or dietary ingredient, and is not manufactured, packaged, or marketed for human consumption, self-experimentation, clinical application, or any use outside properly designed and ethically approved research protocols.